Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Maryam Asgari to Female

This is a "connection" page, showing publications Maryam Asgari has written about Female.

 
Connection Strength
  
 
 
0.954
  
  1. Jorgenson E, Choquet H, Yin J, Hoffmann TJ, Banda Y, Kvale MN, Risch N, Schaefer C, Asgari MM. Genetic ancestry, skin pigmentation, and the risk of cutaneous squamous cell carcinoma in Hispanic/Latino and non-Hispanic white populations. Commun Biol. 2020 12 14; 3(1):765.
    View in: PubMed
    Score: 0.023
  2. Yao Q, Epstein CB, Banskota S, Issner R, Kim Y, Bernstein BE, Pinello L, Asgari MM. Epigenetic Alterations in Keratinocyte Carcinoma. J Invest Dermatol. 2021 05; 141(5):1207-1218.
    View in: PubMed
    Score: 0.023
  3. Asgari MM, Tsai AL, Avalos L, Sokil M, Quesenberry CP. Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults With Atopic Dermatitis. JAMA Dermatol. 2020 10 01; 156(10):1066-1073.
    View in: PubMed
    Score: 0.023
  4. Chavez A, Quesenberry CP, Darbinian J, Asgari MM. Association of Valproic Acid Use, a Potent Histone Deacetylase Inhibitor, and Melanoma Risk. J Invest Dermatol. 2020 12; 140(12):2353-2358.
    View in: PubMed
    Score: 0.022
  5. Roberts MR, Sordillo JE, Kraft P, Asgari MM. Sex-Stratified Polygenic Risk Score Identifies Individuals at Increased Risk of Basal Cell Carcinoma. J Invest Dermatol. 2020 05; 140(5):971-975.
    View in: PubMed
    Score: 0.021
  6. Kim Y, Wojciechowski D, Pattanayak V, Lee H, Asgari MM. Association between Human Leukocyte Antigen Type and Keratinocyte Carcinoma Risk in Renal Transplant Recipients. J Invest Dermatol. 2020 05; 140(5):995-1002.
    View in: PubMed
    Score: 0.021
  7. Kim Y, Su KA, Asgari MM. Correlates of multiple cutaneous squamous cell carcinoma: A retrospective cohort study. J Am Acad Dermatol. 2020 02; 82(2):497-499.
    View in: PubMed
    Score: 0.021
  8. Asgari MM, Carr PL, Bates CK. Closing the Gender Wage Gap and Achieving Professional Equity in Medicine. JAMA. 2019 May 07; 321(17):1665-1666.
    View in: PubMed
    Score: 0.021
  9. Neugebauer R, Su KA, Zhu Z, Sokil M, Chren MM, Friedman GD, Asgari MM. Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study. J Am Acad Dermatol. 2019 Apr; 80(4):998-1005.
    View in: PubMed
    Score: 0.020
  10. Kim Y, Blomberg M, Rifas-Shiman SL, Camargo CA, Gold DR, Thyssen JP, Litonjua AA, Oken E, Asgari MM. Racial/Ethnic Differences in Incidence and Persistence of Childhood Atopic Dermatitis. J Invest Dermatol. 2019 04; 139(4):827-834.
    View in: PubMed
    Score: 0.020
  11. Su KA, Habel LA, Achacoso NS, Friedman GD, Asgari MM. Photosensitizing antihypertensive drug use and risk of cutaneous squamous cell carcinoma. Br J Dermatol. 2018 11; 179(5):1088-1094.
    View in: PubMed
    Score: 0.020
  12. Jorgenson E, Choquet H, Yin J, Asgari MM. Common Mitochondrial Haplogroups and Cutaneous Squamous Cell Carcinoma Risk. Cancer Epidemiol Biomarkers Prev. 2018 07; 27(7):838-841.
    View in: PubMed
    Score: 0.019
  13. Sordillo JE, Kraft P, Wu AC, Asgari MM. Quantifying the Polygenic Contribution to Cutaneous Squamous Cell Carcinoma Risk. J Invest Dermatol. 2018 07; 138(7):1507-1510.
    View in: PubMed
    Score: 0.019
  14. Levandoski KA, Quesenberry CP, Tsai AL, Asgari MM. Herpes Zoster Rates in a Large Cohort of Patients With Systemically Treated Psoriasis. JAMA Dermatol. 2018 02 01; 154(2):218-219.
    View in: PubMed
    Score: 0.019
  15. Neugebauer R, Levandoski KA, Zhu Z, Sokil M, Chren MM, Friedman GD, Asgari MM. A real-world, community-based cohort study comparing the effectiveness of topical fluorouracil versus topical imiquimod for the treatment of actinic keratosis. J Am Acad Dermatol. 2018 04; 78(4):710-716.
    View in: PubMed
    Score: 0.019
  16. Wang W, Jorgenson E, Whittemore AS, Asgari MM. Susceptibility Loci-Associated Cutaneous Squamous Cell Carcinoma Invasiveness. J Invest Dermatol. 2018 03; 138(3):557-561.
    View in: PubMed
    Score: 0.018
  17. Dobry AS, Quesenberry CP, Ray GT, Geier JL, Asgari MM. Serious infections among a large cohort of subjects with systemically treated psoriasis. J Am Acad Dermatol. 2017 Nov; 77(5):838-844.
    View in: PubMed
    Score: 0.018
  18. Asgari MM, Ray GT, Quesenberry CP, Katz KA, Silverberg MJ. Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load. JAMA Dermatol. 2017 09 01; 153(9):892-896.
    View in: PubMed
    Score: 0.018
  19. Asgari MM, Shen L, Sokil MM, Yeh I, Jorgenson E. Prognostic factors and survival in acral lentiginous melanoma. Br J Dermatol. 2017 Aug; 177(2):428-435.
    View in: PubMed
    Score: 0.018
  20. Asgari MM, Chien AJ, Tsai AL, Fireman B, Quesenberry CP. Association between Lithium Use and Melanoma Risk and Mortality: A Population-Based Study. J Invest Dermatol. 2017 10; 137(10):2087-2091.
    View in: PubMed
    Score: 0.018
  21. Asgari MM, Ray GT, Geier JL, Quesenberry CP. Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population. J Am Acad Dermatol. 2017 Apr; 76(4):632-638.
    View in: PubMed
    Score: 0.018
  22. Ray GT, Kulldorff M, Asgari MM. Geographic Clusters of Basal Cell Carcinoma in a Northern California Health Plan Population. JAMA Dermatol. 2016 11 01; 152(11):1218-1224.
    View in: PubMed
    Score: 0.017
  23. Asgari MM, Toland AE, Arron ST. IRF4 Polymorphism Is Associated with Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients: A Pigment-Independent Phenomenon. J Invest Dermatol. 2017 01; 137(1):251-253.
    View in: PubMed
    Score: 0.017
  24. Asgari MM, Wang W, Ioannidis NM, Itnyre J, Hoffmann T, Jorgenson E, Whittemore AS. Identification of Susceptibility Loci for Cutaneous Squamous Cell Carcinoma. J Invest Dermatol. 2016 05; 136(5):930-937.
    View in: PubMed
    Score: 0.016
  25. Asgari MM, Moffet HH, Ray GT, Quesenberry CP. Trends in Basal Cell Carcinoma Incidence and Identification of High-Risk Subgroups, 1998-2012. JAMA Dermatol. 2015 Sep; 151(9):976-81.
    View in: PubMed
    Score: 0.016
  26. Moore MM, Geller AC, Warton EM, Schwalbe J, Asgari MM. Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011. J Am Acad Dermatol. 2015 Oct; 73(4):630-6.
    View in: PubMed
    Score: 0.016
  27. Asgari MM, Arron ST, Warton EM, Quesenberry CP, Weisshaar D. Sirolimus use and risk of cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients (SOTRs). J Am Acad Dermatol. 2015 Sep; 73(3):444-50.
    View in: PubMed
    Score: 0.016
  28. Asgari MM, Warton EM, Whittemore AS. Family history of skin cancer is associated with increased risk of cutaneous squamous cell carcinoma. Dermatol Surg. 2015 Apr; 41(4):481-6.
    View in: PubMed
    Score: 0.015
  29. Asgari MM, Eide MJ, Warton M, Fletcher SW. Comparing characteristics of melanoma cases arising in health maintenance organizations with state and national registries. Melanoma Res. 2014 Aug; 24(4):381-7.
    View in: PubMed
    Score: 0.015
  30. Asgari MM, Sokil MM, Warton EM, Iyer J, Paulson KG, Nghiem P. Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma. JAMA Dermatol. 2014 Jul; 150(7):716-23.
    View in: PubMed
    Score: 0.015
  31. Asgari MM, Warton EM, Quesenberry CP, Koralek DO, Taylor M. Risk of subsequent cutaneous squamous cell carcinoma in patients with melanoma. J Am Acad Dermatol. 2014 Sep; 71(3):521-8.
    View in: PubMed
    Score: 0.015
  32. Asgari MM, Wu JJ, Gelfand JM, Salman C, Curtis JR, Harrold LR, Herrinton LJ. Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009. Pharmacoepidemiol Drug Saf. 2013 Aug; 22(8):842-9.
    View in: PubMed
    Score: 0.014
  33. Silverberg MJ, Leyden W, Warton EM, Quesenberry CP, Engels EA, Asgari MM. HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst. 2013 Mar 06; 105(5):350-60.
    View in: PubMed
    Score: 0.013
  34. Asgari MM, Eide MJ, Warton EM, Fletcher SW. Validation of a large basal cell carcinoma registry. J Registry Manag. 2013; 40(2):65-9.
    View in: PubMed
    Score: 0.013
  35. Gordon NP, Caan BJ, Asgari MM. Variation in vitamin D supplementation among adults in a multi-race/ethnic health plan population, 2008. Nutr J. 2012 Dec 11; 11:104.
    View in: PubMed
    Score: 0.013
  36. Asgari MM, Brasky TM, White E. Association of vitamin A and carotenoid intake with melanoma risk in a large prospective cohort. J Invest Dermatol. 2012 Jun; 132(6):1573-82.
    View in: PubMed
    Score: 0.013
  37. Asgari MM, Warton EM, Neugebauer R, Chren MM. Predictors of patient satisfaction with Mohs surgery: analysis of preoperative, intraoperative, and postoperative factors in a prospective cohort. Arch Dermatol. 2011 Dec; 147(12):1387-94.
    View in: PubMed
    Score: 0.012
  38. Asgari MM, Chren MM, Warton EM, Friedman GD, White E. Supplement use and risk of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 2011 Dec; 65(6):1145-51.
    View in: PubMed
    Score: 0.012
  39. Asgari MM, White E, Warton EM, Hararah MK, Friedman GD, Chren MM. Association of tea consumption and cutaneous squamous cell carcinoma. Nutr Cancer. 2011; 63(2):314-8.
    View in: PubMed
    Score: 0.012
  40. Asgari MM, Chren MM, Warton EM, Friedman GD, White E. Association between nonsteroidal anti-inflammatory drug use and cutaneous squamous cell carcinoma. Arch Dermatol. 2010 Apr; 146(4):388-95.
    View in: PubMed
    Score: 0.011
  41. Asgari MM, Efird JT, Warton EM, Friedman GD. Potential risk factors for cutaneous squamous cell carcinoma include oral contraceptives: results of a nested case-control study. Int J Environ Res Public Health. 2010 02; 7(2):427-42.
    View in: PubMed
    Score: 0.011
  42. Asgari MM, Tang J, Warton ME, Chren MM, Quesenberry CP, Bikle D, Horst RL, Orentreich N, Vogelman JH, Friedman GD. Association of prediagnostic serum vitamin D levels with the development of basal cell carcinoma. J Invest Dermatol. 2010 May; 130(5):1438-43.
    View in: PubMed
    Score: 0.011
  43. Asgari MM, Maruti SS, Kushi LH, White E. Antioxidant supplementation and risk of incident melanomas: results of a large prospective cohort study. Arch Dermatol. 2009 Aug; 145(8):879-82.
    View in: PubMed
    Score: 0.010
  44. Asgari MM, Tang J, Epstein EH, Chren MM, Warton EM, Quesenberry CP, Go AS, Friedman GD. Statin use and risk of basal cell carcinoma. J Am Acad Dermatol. 2009 Jul; 61(1):66-72.
    View in: PubMed
    Score: 0.010
  45. Asgari MM, Bertenthal D, Sen S, Sahay A, Chren MM. Patient satisfaction after treatment of nonmelanoma skin cancer. Dermatol Surg. 2009 Jul; 35(7):1041-9.
    View in: PubMed
    Score: 0.010
  46. Asgari MM, Maruti SS, Kushi LH, White E. A cohort study of vitamin D intake and melanoma risk. J Invest Dermatol. 2009 Jul; 129(7):1675-80.
    View in: PubMed
    Score: 0.010
  47. Asgari MM, Maruti SS, White E. A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence. J Natl Cancer Inst. 2008 Jul 02; 100(13):967-71.
    View in: PubMed
    Score: 0.010
  48. Asgari MM, Kiviat NB, Critchlow CW, Stern JE, Argenyi ZB, Raugi GJ, Berg D, Odland PB, Hawes SE, de Villiers EM. Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. J Invest Dermatol. 2008 Jun; 128(6):1409-17.
    View in: PubMed
    Score: 0.009
  49. Hwang JC, Huhmann LB, Cho K, Goryachev SD, Starink N, Weinstock MA, Asgari MM, Zheng C, Lu C, Feldman TC, Do NV, Gaziano JM, Semenov YR, Hurlbert MS, Fillmore NR, Hartman RI. Identification of Risk Factors for Acral Melanoma in US Veterans. JAMA Dermatol. 2026 03 01; 162(3):279-291.
    View in: PubMed
    Score: 0.008
  50. Asgari M, Odland P. Nasalis island pedicle flap in nasal ala reconstruction. Dermatol Surg. 2005 Apr; 31(4):448-52.
    View in: PubMed
    Score: 0.008
  51. Tan AJ, Archila M, Barbieri JS, Mostaghimi A, Scherer AM, Perez-Chada LM, Asgari MM, Gelfand JM, Noe MH. Understanding patient perspectives on vaccine decision making in adults with autoimmune bullous diseases: a qualitative study. Arch Dermatol Res. 2024 Apr 18; 316(5):125.
    View in: PubMed
    Score: 0.007
  52. Asgari M, Rubin BP, Hornung RL. Neonate with a fibrosarcoma and consumptive coagulopathy. J Am Acad Dermatol. 2004 Feb; 50(2 Suppl):S23-5.
    View in: PubMed
    Score: 0.007
  53. Hedderson MM, Asgari MM, Xu F, Quesenberry CP, Sridhar S, Geier J, Lemeshow AR. Rates of malignancies among patients with moderate to severe atopic dermatitis: a retrospective cohort study. BMJ Open. 2023 03 10; 13(3):e071172.
    View in: PubMed
    Score: 0.007
  54. Noe MH, Archila M, Barbieri JS, Goldman N, Lopez CG, Mostaghimi A, Scherer AM, Tan AJ, Perez-Chada LM, Asgari MM, Gelfand JM. The patient perspective on vaccine uptake in adults with psoriasis and eczema. Arch Dermatol Res. 2023 Aug; 315(6):1583-1592.
    View in: PubMed
    Score: 0.007
  55. Hedderson MM, Asgari MM, Xu F, Quesenberry CP, Sridhar S, Geier J, Lemeshow AR. Rates of cardiovascular events among patients with moderate-to-severe atopic dermatitis in an integrated health care system: A retrospective cohort study. PLoS One. 2022; 17(11):e0277469.
    View in: PubMed
    Score: 0.007
  56. Tang K, Seo J, Tiu BC, Le TK, Pahalyants V, Raval NS, Ugwu-Dike PO, Zubiri L, Naranbhai V, Carrington M, Gusev A, Reynolds KL, LeBoeuf NR, Asgari MM, Kwatra SG, Semenov YR. Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Therapy. JAMA Dermatol. 2022 Feb 01; 158(2):189-193.
    View in: PubMed
    Score: 0.006
  57. Strickley JD, Messerschmidt JL, Awad ME, Li T, Hasegawa T, Ha DT, Nabeta HW, Bevins PA, Ngo KH, Asgari MM, Nazarian RM, Neel VA, Jenson AB, Joh J, Demehri S. Immunity to commensal papillomaviruses protects against skin cancer. Nature. 2019 11; 575(7783):519-522.
    View in: PubMed
    Score: 0.005
  58. Ameri AH, Mooradian MJ, Emerick KS, Park JC, Wirth LJ, Asgari MM, Tsao H, Lawrence D, Sullivan RJ, Demehri S. Immunotherapeutic strategies for cutaneous squamous cell carcinoma prevention in xeroderma pigmentosum. Br J Dermatol. 2019 11; 181(5):1095-1097.
    View in: PubMed
    Score: 0.005
  59. Feng J, Kim Y, Kornides ML, McRee AL, Mays D, Asgari MM, Gilkey MB. Correlates of positive parental attitudes towards adolescent indoor tanning in the U.S.A. Br J Dermatol. 2018 12; 179(6):1412-1413.
    View in: PubMed
    Score: 0.005
  60. Albrecht J, Adamson AS, Barbieri JS, Bennett DD, Kiracofe EA, Kourosh AS, Leslie KS, Merola JF, Nguyen J, Siegfried E, Strickland N, Olbricht S, Asgari MM. Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment. J Am Acad Dermatol. 2019 02; 80(2):577-578.
    View in: PubMed
    Score: 0.005
  61. Wang W, Jorgenson E, Ioannidis NM, Asgari MM, Whittemore AS. A Prediction Tool to Facilitate Risk-Stratified Screening for Squamous Cell Skin Cancer. J Invest Dermatol. 2018 12; 138(12):2589-2594.
    View in: PubMed
    Score: 0.005
  62. Secrest AM, Asgari MM, Kourosh AS, Barbieri JS, Albrecht J. Prior authorizations for dermatologic medications: An American Academy of Dermatology survey of US dermatology providers and staff. J Am Acad Dermatol. 2017 10; 77(4):784-786.
    View in: PubMed
    Score: 0.005
  63. Lowenstein SE, Garrett G, Toland AE, Jambusaria-Pahlajani A, Asgari MM, Green A, Engels EA, Arron ST. Risk prediction tools for keratinocyte carcinoma after solid organ transplantation: a review of the literature. Br J Dermatol. 2017 Nov; 177(5):1202-1207.
    View in: PubMed
    Score: 0.005
  64. Jiang AJ, Eide MJ, Alexander GL, Altschuler A, Asgari MM, Geller AC, Fletcher SW, Halpern AC, Weinstock MA. Providers' Experiences with a Melanoma Web-Based Course: a Discussion on Barriers and Intentions. J Cancer Educ. 2017 Jun; 32(2):272-279.
    View in: PubMed
    Score: 0.004
  65. Gilkey MB, Mays D, Asgari MM, Kornides ML, McRee AL. Parental Support for Age-based Indoor Tanning Restrictions. Am J Prev Med. 2017 Oct; 53(4):473-480.
    View in: PubMed
    Score: 0.004
  66. Asgari MM, Begos DG. Spontaneous splenic rupture in infectious mononucleosis: a review. Yale J Biol Med. 1997 Mar-Apr; 70(2):175-82.
    View in: PubMed
    Score: 0.004
  67. Blomberg M, Rifas-Shiman SL, Camargo CA, Gold DR, Asgari MM, Thyssen JP, Litonjua AA, Gillman MW, Oken E. Low Maternal Prenatal 25-Hydroxyvitamin D Blood Levels Are Associated with Childhood Atopic Dermatitis. J Invest Dermatol. 2017 06; 137(6):1380-1384.
    View in: PubMed
    Score: 0.004
  68. Moshiri AS, Doumani R, Yelistratova L, Blom A, Lachance K, Shinohara MM, Delaney M, Chang O, McArdle S, Thomas H, Asgari MM, Huang ML, Schwartz SM, Nghiem P. Polyomavirus-Negative Merkel Cell Carcinoma: A More Aggressive Subtype Based on Analysis of 282 Cases Using Multimodal Tumor Virus Detection. J Invest Dermatol. 2017 04; 137(4):819-827.
    View in: PubMed
    Score: 0.004
  69. Curtis JR, Harrold LR, Asgari MM, Deodhar A, Salman C, Gelfand JM, Wu JJ, Herrinton LJ. Diagnostic Prevalence of Ankylosing Spondylitis Using Computerized Health Care Data, 1996 to 2009: Underrecognition in a US Health Care Setting. Perm J. 2016; 20(4):15-151.
    View in: PubMed
    Score: 0.004
  70. Iyer JG, Parvathaneni K, Bhatia S, Tarabadkar ES, Blom A, Doumani R, McKenzie J, Asgari MM, Nghiem P. Paraneoplastic syndromes (PNS) associated with Merkel cell carcinoma (MCC): A case series of 8 patients highlighting different clinical manifestations. J Am Acad Dermatol. 2016 Sep; 75(3):541-547.
    View in: PubMed
    Score: 0.004
  71. Herrinton LJ, Harrold L, Salman C, Liu L, Goldfien R, Asgari M, Gelfand JM, Wu JJ, Curtis JR. Population Variations in Rheumatoid Arthritis Treatment and Outcomes, Northern California, 1998-2009. Perm J. 2016; 20(1):4-12.
    View in: PubMed
    Score: 0.004
  72. Mansh M, Binstock M, Williams K, Hafeez F, Kim J, Glidden D, Boettger R, Hays S, Kukreja J, Golden J, Asgari MM, Chin-Hong P, Singer JP, Arron ST. Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients. Am J Transplant. 2016 Jan; 16(1):262-70.
    View in: PubMed
    Score: 0.004
  73. Talaiezadeh AH, Asgari M, Zargar MA. Mortality and Morbidity and Disease Free Survival after D1 and D2 Gastrectomy for Stomach Adenocarcinomas. Asian Pac J Cancer Prev. 2015; 16(13):5253-6.
    View in: PubMed
    Score: 0.004
  74. Paulson KG, Iyer JG, Simonson WT, Blom A, Thibodeau RM, Schmidt M, Pietromonaco S, Sokil M, Warton EM, Asgari MM, Nghiem P. CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based study. Am J Clin Pathol. 2014 Oct; 142(4):452-8.
    View in: PubMed
    Score: 0.004
  75. Wu JJ, Liu L, Asgari MM, Curtis JR, Harrold L, Salman C, Herrinton LJ. Initiation of TNF inhibitor therapy and change in physiologic measures in psoriasis. J Eur Acad Dermatol Venereol. 2014 Oct; 28(10):1380-7.
    View in: PubMed
    Score: 0.004
  76. Eide MJ, Asgari MM, Fletcher SW, Geller AC, Halpern AC, Shaikh WR, Li L, Alexander GL, Altschuler A, Dusza SW, Marghoob AA, Quigley EA, Weinstock MA. Effects on skills and practice from a web-based skin cancer course for primary care providers. J Am Board Fam Med. 2013 Nov-Dec; 26(6):648-57.
    View in: PubMed
    Score: 0.004
  77. Harrold LR, Salman C, Shoor S, Curtis JR, Asgari MM, Gelfand JM, Wu JJ, Herrinton LJ. Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996-2009. J Rheumatol. 2013 Jul; 40(7):1218-25.
    View in: PubMed
    Score: 0.003
  78. Gamba CA, Swetter SM, Stefanick ML, Kubo J, Desai M, Spaunhurst KM, Sinha AA, Asgari MM, Sturgeon S, Tang JY. Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women's Health Initiative. Cancer. 2013 Apr 15; 119(8):1562-9.
    View in: PubMed
    Score: 0.003
  79. Paulson KG, Iyer JG, Blom A, Warton EM, Sokil M, Yelistratova L, Schuman L, Nagase K, Bhatia S, Asgari MM, Nghiem P. Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage. J Invest Dermatol. 2013 Mar; 133(3):642-646.
    View in: PubMed
    Score: 0.003
  80. Friedman GD, Asgari MM, Warton EM, Chan J, Habel LA. Antihypertensive drugs and lip cancer in non-Hispanic whites. Arch Intern Med. 2012 Sep 10; 172(16):1246-51.
    View in: PubMed
    Score: 0.003
  81. Loeb KR, Asgari MM, Hawes SE, Feng Q, Stern JE, Jiang M, Argenyi ZB, de Villiers EM, Kiviat NB. Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas. PLoS One. 2012; 7(4):e34422.
    View in: PubMed
    Score: 0.003
  82. Brasky TM, Potter JD, Kristal AR, Patterson RE, Peters U, Asgari MM, Thornquist MD, White E. Non-steroidal anti-inflammatory drugs and cancer incidence by sex in the VITamins And Lifestyle (VITAL) cohort. Cancer Causes Control. 2012 Mar; 23(3):431-44.
    View in: PubMed
    Score: 0.003
  83. Wilson LS, Pregenzer M, Basu R, Bertenthal D, Torres J, Asgari M, Chren MM. Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting. Dermatol Surg. 2012 Apr; 38(4):570-84.
    View in: PubMed
    Score: 0.003
  84. Bowen DJ, Hay JL, Mayer J, Kuniyuki A, Meischke H, Harris J, Asgari M, Shoveller J, Press N, Burke W. Predictors of recruited melanoma families into a behavioral intervention project. Contemp Clin Trials. 2012 Jan; 33(1):85-92.
    View in: PubMed
    Score: 0.003
  85. Harris JN, Hay J, Kuniyuki A, Asgari MM, Press N, Bowen DJ. Using a family systems approach to investigate cancer risk communication within melanoma families. Psychooncology. 2010 Oct; 19(10):1102-11.
    View in: PubMed
    Score: 0.003
  86. Tang JY, Wu A, Linos E, Parimi N, Lee W, Aszterbaum M, Asgari MM, Bickers DR, Epstein EH. High prevalence of vitamin D deficiency in patients with basal cell nevus syndrome. Arch Dermatol. 2010 Oct; 146(10):1105-10.
    View in: PubMed
    Score: 0.003
  87. Eide MJ, Krajenta R, Johnson D, Long JJ, Jacobsen G, Asgari MM, Lim HW, Johnson CC. Identification of patients with nonmelanoma skin cancer using health maintenance organization claims data. Am J Epidemiol. 2010 Jan 01; 171(1):123-8.
    View in: PubMed
    Score: 0.003
  88. Akhyani M, Chams-Davatchi C, Naraghi Z, Daneshpazhooh M, Toosi S, Asgari M, Malekhami F. Cervicovaginal involvement in pemphigus vulgaris: a clinical study of 77 cases. Br J Dermatol. 2008 Mar; 158(3):478-82.
    View in: PubMed
    Score: 0.002
  89. Asgari MM, DuBois A, Asgari M, Gent J, Beckett WS. Association of ambient air quality with children's lung function in urban and rural Iran. Arch Environ Health. 1998 May-Jun; 53(3):222-30.
    View in: PubMed
    Score: 0.001
  90. Puce A, Allison T, Asgari M, Gore JC, McCarthy G. Differential sensitivity of human visual cortex to faces, letterstrings, and textures: a functional magnetic resonance imaging study. J Neurosci. 1996 Aug 15; 16(16):5205-15.
    View in: PubMed
    Score: 0.001
  91. Asgari M, Owrang A. Results of skin test surveys for systemic mycoses in Iran. Mycopathol Mycol Appl. 1970; 41(1):91-106.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)